1,776 results on '"scleroderma, diffuse"'
Search Results
52. Intralesional Injection of STS in Treatment of Calcinosis (STSINJ)
53. The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life (ASScERT-QoL)
54. Sildenafil for Early Pulmonary Vascular Disease in Scleroderma (SEPVADIS)
55. Yoga Adjunct for Scleroderma (GYYB)
56. Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis
57. Hand ScleroDerma Lived Experience Scale in Individuals with Systemic Sclerosis
58. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509 in Participants With Systemic Sclerosis
59. Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma (DupiMorph)
60. Study on the Efficacy of Autologous Fat Grafting in Improving Hair Transplantation Outcomes for Patients With Localized Scleroderma-Related Alopecia
61. A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis
62. TENS in Scleroderma
63. Rare AutoImmune SElf-management Programme Development (RAISE)
64. A Study of MK-2225 in Healthy Participants (MK-2225-003)
65. CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101 (CARTIMMUNE)
66. Hyaluronidase Via LADD Scleroderma-induced Microstomia
67. Exercise in People With Systemic Sclerosis (SScPF)
68. Longitudinal Spatial Frequency Domain Imaging Study (SFDI)
69. Laser Treatment for the Improvement of Scars and Scleroderma
70. Effectiveness of Cannabinoids on Appetite in Scleroderma
71. Assessment of Serum CD25 Level in Systemic Sclerosis Patients with or Without Interstitial Lung Disease (ILD)
72. Safety and Efficacy of Itacitinib in Adults with Systemic Sclerosis (SCLERITA)
73. Investigation of Respiratory Muscle Sarcopenia in Patients with Systemic Sclerosis
74. Periodontal Health Status in Patients with Systemic Sclerosis
75. Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism (MARIGYN)
76. Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre (SCLERESO)
77. 6-minute Pegboard Ring Test in Patients with Scleroderma
78. Functional Performance and Biopsychosocial Characteristics in Individuals with Systemic Sclerosis
79. ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS (PLAQUETTOLUP)
80. A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients with Autoimmune Disease
81. Making it Work Program for Systemic Sclerosis
82. Nailfold Capillaroscopic Pattern Changes and Its Correlation with Interstitial Lung Disease (ILD) in Systemic Sclerosis (SSc) Patients.
83. Metabolomic Analysis of Systemic Sclerosis (SCLEROMICS)
84. Efficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung Disease (SCLEROJAKI)
85. Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease (LUNGSCLEROCT)
86. Evaluation of Muscle Involvement in Systemic Sclerosis (MUSSc)
87. Interstitial Lung Disease Trajectories in Patients With Systemic Sclerosis (SCLEROPIDEVOL)
88. Periodontal Microbiota in Systemic Sclerosis (Periomicross)
89. Effect of the Use of Specific Oral Hygiene Devices on Gingival Health Among Patients With Systemic Sclerosis (ScleroBross)
90. Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis
91. Respiratory Muscle Strength and Aerobic Capacity in Scleroderma
92. KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis
93. Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis (SSc)
94. Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung Disease Related to Systemic Sclerosis (EVER-ILD 3)
95. Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking (SCLEROBREST)
96. Validity and Reliability of the Turkish Version of HAnDE
97. The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis
98. Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
99. Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis (AST-MOMA)
100. AUTOANTIBODIES AND SYSTEMIC SCLEROSIS (AUTO)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.